Vincerx Pharma, Inc. Payments for Underwriting Expense
Vincerx Pharma, Inc. reported Payments for Underwriting Expense of $16.90 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForUnderwritingExpense · last filed 2024-11-12
- Vincerx Pharma, Inc. payments for underwriting expense for the quarter ending 2024-09-30 was $0.00.
- Vincerx Pharma, Inc. payments for underwriting expense for the quarter ending 2024-06-30 was -$900.00K.
- Vincerx Pharma, Inc. payments for underwriting expense for the quarter ending 2024-03-31 was $17.80M.
| Period end | Payments for Underwriting Expense 3 month | Payments for Underwriting Expense 6 month | Payments for Underwriting Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$900.00K derived: sum of 2 quarters · filed 2024-11-12 | $16.90M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $16.90M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $17.80M 10-Q · filed 2024-05-14 |